Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
007390.KQ Stock Summary
Top 10 Correlated ETFs
007390.KQ
In the News
007390.KQ Financial details
Company Rating
Sell
Market Cap
479.9B
Income
-11.29B
Revenue
19.35B
Book val./share
965.05
Cash/share
-
Dividend
-
Dividend %
-
Employees
64
Optionable
No
Shortable
Yes
Earnings
11 May 2024
P/E
-101.22
Forward P/E
-
PEG
-125.75
P/S
43.85
P/B
6.42
P/C
-
P/FCF
-247.66
Quick Ratio
10.61
Current Ratio
12.46
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-177.05
EPS next Y
-
EPS next Q
-
EPS this Y
4.86%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-3.46%
Revenue Q/Q
3.82%
EPS Q/Q
451.75%
-
-
-
-
SMA20
19.63%
SMA50
9.56%
SMA100
18.89%
Inst Own
-
Inst Trans
-
ROA
-6%
ROE
-7%
ROC
-0.05%
Gross Margin
47%
Oper. Margin
-27%
Profit Margin
-38%
Payout
-
Shs Outstand
52.75M
Shs Float
42.27M
-
-
-
-
Target Price
-
52W Range
6880.0-25500.0
52W High
-61.33%
52W Low
+43.31%
RSI
77.47
Rel Volume
2.93
Avg Volume
298.82K
Volume
876.03K
Perf Week
31.64%
Perf Month
33.79%
Perf Quarter
31.29%
Perf Half Y
29.91%
-
-
-
-
Beta
0.553059
-
-
Volatility
991.69%, 868.68%
Prev Close
0.2%
Price
9860
Change
-3.43%
007390.KQ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 415.17 | 273.24 | 329.62 | 344.13 | 301.62 | |
Net income per share | 16.23 | -308.38 | -518.71 | -163.86 | -171.83 | |
Operating cash flow per share | 6.43 | -84.28 | -164.37 | -237.34 | 0 | |
Free cash flow per share | -19.18 | -128.77 | -171.74 | -297.92 | 0 | |
Cash per share | 832.73 | 792.57 | 527.13 | 499.02 | 0 | |
Book value per share | 1.47K | 1.02K | 985.33 | 912.55 | 965.05 | |
Tangible book value per share | 1.39K | 955.5 | 918.13 | 851.11 | 1.08K | |
Share holders equity per share | 1.47K | 1.02K | 985.33 | 912.55 | 965.05 | |
Interest debt per share | 70.98 | 210.57 | 31.21 | 424.28 | 0 | |
Market cap | 366.22B | 627.2B | 1099.16B | 939.53B | 536.35B | |
Enterprise value | 350.57B | 599.97B | 1069.15B | 933.81B | 536.35B | |
P/E ratio | 406.01 | -33.24 | -34.32 | -91.54 | -48.65 | |
Price to sales ratio | 15.87 | 37.51 | 54 | 43.59 | 27.72 | |
POCF ratio | 1.02K | -121.62 | -108.29 | -63.2 | 0 | |
PFCF ratio | -343.58 | -79.6 | -103.64 | -50.35 | 0 | |
P/B Ratio | 4.47 | 10.01 | 18.06 | 16.44 | 8.66 | |
PTB ratio | 4.47 | 10.01 | 18.06 | 16.44 | 8.66 | |
EV to sales | 15.19 | 35.88 | 52.53 | 43.32 | 27.72 | |
Enterprise value over EBITDA | 111.24 | -97.58 | -154.93 | -148.55 | -52.62 | |
EV to operating cash flow | 980.58 | -116.34 | -105.34 | -62.82 | 0 | |
EV to free cash flow | -328.9 | -76.15 | -100.81 | -50.04 | 0 | |
Earnings yield | 0 | -0.03 | -0.03 | -0.01 | -0.02 | |
Free cash flow yield | 0 | -0.01 | -0.01 | -0.02 | 0 | |
Debt to equity | 0.05 | 0.2 | 0.02 | 0.43 | 0 | |
Debt to assets | 0.04 | 0.14 | 0.02 | 0.26 | 0 | |
Net debt to EBITDA | -4.96 | 4.43 | 4.35 | 0.91 | 0 | |
Current ratio | 6.32 | 2.75 | 6.52 | 1.88 | 0 | |
Interest coverage | 8.3 | -15.78 | -11.31 | -4.29 | 0 | |
Income quality | 0.4 | 0.27 | 0.34 | 1.67 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0.01 | 0 | 0 | |
Research and developement to revenue | 0.08 | 0.1 | 0.07 | 0.07 | 0 | |
Intangibles to total assets | 0.05 | 0.05 | 0.06 | 0.04 | 0 | |
Capex to operating cash flow | -3.98 | 0.53 | 0.04 | 0.26 | 0 | |
Capex to revenue | -0.06 | -0.16 | -0.02 | -0.18 | 0 | |
Capex to depreciation | -1.02 | -1.75 | -0.29 | -3.44 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 733.59 | 2.67K | 3.39K | 1.83K | 1.93K | |
ROIC | 0.02 | -0.11 | -0.14 | -0.12 | -0.17 | |
Return on tangible assets | 0.01 | -0.23 | -0.49 | -0.11 | -0.16 | |
Graham Net | 741.15 | 492.83 | 483.22 | 302 | 0 | |
Working capital | 47.05B | 35.82B | 36.32B | 31.41B | 0 | |
Tangible asset value | 77.48B | 58.47B | 56.7B | 53.31B | 68.99B | |
Net current asset value | 44.67B | 33.27B | 34.1B | 30.3B | 0 | |
Invested capital | 0.05 | 0.2 | 0.02 | 0.43 | 0 | |
Average receivables | 0 | 5.14B | 5.11B | 18.34B | 15.33B | |
Average payables | 0 | 338.87M | 1.05B | 1.41B | 534.86M | |
Average inventory | 0 | 3.14B | 3.15B | 3.1B | 1.53B | |
Days sales outstanding | 96.25 | 91.76 | 107.98 | 519.25 | 0 | |
Days payables outstanding | 10.87 | 13.22 | 51.82 | 29.84 | 0 | |
Days of inventory on hand | 107.04 | 115.95 | 93.52 | 85.1 | 0 | |
Receivables turnover | 3.79 | 3.98 | 3.38 | 0.7 | 0 | |
Payables turnover | 33.59 | 27.6 | 7.04 | 12.23 | 0 | |
Inventory turnover | 3.41 | 3.15 | 3.9 | 4.29 | 0 | |
ROE | 0.01 | -0.3 | -0.53 | -0.18 | -0.18 | |
Capex per share | -25.61 | -44.49 | -7.37 | -60.59 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 93.99 | 92.94 | 88.27 | 60.15 | 62.45 | |
Net income per share | 47.94 | -46.12 | -26.39 | -16.04 | -88.5 | |
Operating cash flow per share | 77.17 | 213.84 | -151.19 | -38.37 | 0 | |
Free cash flow per share | 21.58 | 115.69 | -144.69 | -43.32 | 0 | |
Cash per share | 499 | 628.73 | 465.17 | 526.26 | 0 | |
Book value per share | 912.53 | 879.58 | 1.06K | 1.05K | 965.05 | |
Tangible book value per share | 851.08 | 818.9 | 1K | 990.8 | 1.08K | |
Share holders equity per share | 912.53 | 879.58 | 1.06K | 1.05K | 965.05 | |
Interest debt per share | 407.73 | 420.19 | 15.44 | 14.38 | 0 | |
Market cap | 955.22B | 1127.56B | 528.01B | 496.58B | 536.35B | |
Enterprise value | 949.49B | 1114.55B | 499.41B | 465.57B | 536.35B | |
P/E ratio | 79.53 | -97.56 | -77.97 | -120.61 | -23.62 | |
Price to sales ratio | 162.26 | 193.67 | 93.24 | 128.68 | 133.87 | |
POCF ratio | 197.61 | 84.17 | -54.43 | -201.72 | 0 | |
PFCF ratio | 706.53 | 155.59 | -56.88 | -178.67 | 0 | |
P/B Ratio | 16.71 | 20.46 | 7.76 | 7.38 | 8.66 | |
PTB ratio | 16.71 | 20.46 | 7.76 | 7.38 | 8.66 | |
EV to sales | 161.29 | 191.43 | 88.19 | 120.64 | 133.87 | |
Enterprise value over EBITDA | 291.66 | -591.33 | -639.03 | -334.4 | -100.18 | |
EV to operating cash flow | 196.43 | 83.2 | -51.48 | -189.12 | 0 | |
EV to free cash flow | 702.3 | 153.79 | -53.8 | -167.51 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | -0.01 | |
Free cash flow yield | 0 | 0.01 | -0.02 | -0.01 | 0 | |
Debt to equity | 0.43 | 0.47 | 0.01 | 0.01 | 0 | |
Debt to assets | 0.26 | 0.28 | 0.01 | 0.01 | 0 | |
Net debt to EBITDA | -1.76 | 6.9 | 36.59 | 22.27 | 0 | |
Current ratio | 1.88 | 1.68 | 12.46 | 15.5 | 0 | |
Interest coverage | 4.53 | -3.17 | -2.63 | -301.38 | 0 | |
Income quality | 1.11 | -4.64 | 6.79 | 2.39 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Research and developement to revenue | 0.16 | 0.04 | 0.08 | 0.09 | 0 | |
Intangibles to total assets | 0.04 | 0.04 | 0.05 | 0.05 | 0 | |
Capex to operating cash flow | -0.72 | -0.46 | -0.04 | 0.13 | 0 | |
Capex to revenue | -0.59 | -1.06 | 0.07 | -0.08 | 0 | |
Capex to depreciation | -24.65 | -19.24 | 2.45 | -0.89 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 992.08 | 955.41 | 793.58 | 615.24 | 1.39K | |
ROIC | 0.02 | -0.03 | -0.01 | -0.02 | -0.09 | |
Return on tangible assets | 0.03 | -0.03 | -0.02 | -0.01 | -0.08 | |
Graham Net | 301.99 | 246.65 | 475.91 | 526.38 | 0 | |
Working capital | 31.41B | 23.84B | 35.77B | 41.22B | 0 | |
Tangible asset value | 53.31B | 51.3B | 64.29B | 63.57B | 68.99B | |
Net current asset value | 30.3B | 22.64B | 34.69B | 38.71B | 0 | |
Invested capital | 0.43 | 0.47 | 0.01 | 0.01 | 0 | |
Average receivables | 23.36B | 22.44B | 9.11B | 4.35B | 2.35B | |
Average payables | 1.35B | 1.05B | 848.29M | 547.29M | 218.58M | |
Average inventory | 3.66B | 3.26B | 3.63B | 3.74B | 1.84B | |
Days sales outstanding | 468.78 | 219.68 | 63.63 | 109.45 | 0 | |
Days payables outstanding | 40.84 | 29.29 | 18.62 | 16.07 | 0 | |
Days of inventory on hand | 116.46 | 97.77 | 107.29 | 135.45 | 0 | |
Receivables turnover | 0.19 | 0.41 | 1.41 | 0.82 | 0 | |
Payables turnover | 2.2 | 3.07 | 4.83 | 5.6 | 0 | |
Inventory turnover | 0.77 | 0.92 | 0.84 | 0.66 | 0 | |
ROE | 0.05 | -0.05 | -0.02 | -0.02 | -0.09 | |
Capex per share | -55.59 | -98.15 | 6.5 | -4.95 | 0 |
007390.KQ Frequently Asked Questions
What is NatureCell Co.,Ltd. stock symbol ?
NatureCell Co.,Ltd. is a KR stock and trading under the symbol 007390.KQ
What is NatureCell Co.,Ltd. stock quote today ?
NatureCell Co.,Ltd. stock price is $9860 today.
Is NatureCell Co.,Ltd. stock public?
Yes, NatureCell Co.,Ltd. is a publicly traded company.